Search

Search Constraints

You searched for: Author/Creator Hoeben, Rob C

Search Results

11. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Issue 2 (20th October 2020)

12. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Issue 2 (20th October 2020)

13. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Issue 2 (20th October 2020)

14. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Issue 2 (20th October 2020)

15. Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy. Issue 7 (19th July 2022)

16. THER-02. Pediatric brain tumor cultures reveal differential susceptibility to four oncolytic viruses. (3rd June 2022)